Machine Learning Metabolomics Profiling of Dietary Interventions from a Six-Week Randomised Trial.
Kouraki A, Nogal A, Nocun W, Louca P, Vijay A, Wong K, Michelotti GA, Menni C, Valdes AM.
Metabolites. 2024 May 29. 14(6). PMID: 38921446
Links
Bibliography
Cross-sectional analyses of metabolites across biological samples mediating dietary acid load and chronic kidney disease.
Attaye I, Beynon-Cobb B, Louca P, Nogal A, Visconti A, Tettamanzi F, Wong K, Michellotti G, Spector TD, Falchi M, Bell JT, Menni C.
iScience. 2024 Mar 15. 27(3):109132. PMID: 38433906
Predictive metabolites for incident myocardial infarction: a two-step meta-analysis of individual patient data from six cohorts comprising 7897 individuals from the COnsortium of METabolomics Studies.
Nogal A, Alkis T, Lee Y, Kifer D, Hu J, Murphy RA, Huang Z, Wang-Sattler R, Kastenmüler G, Linkohr B, Barrios C, Crespo M, Gieger C, Peters A, Price J, Rexrode KM, Yu B, Menni C.
Cardiovasc Res. 2023 12 30. 119(17):2743-2754. PMID: 37706562
A Fecal Metabolite Signature of Impaired Fasting Glucose: Results From Two Independent Population-Based Cohorts.
Nogal A, Tettamanzi F, Dong Q, Louca P, Visconti A, Christiansen C, Breuninger T, Linseisen J, Grallert H, Wawro N, Asnicar F, Wong K, Baleanu AF, Michelotti GA, Segata N, Falchi M, Peters A, Franks PW, Bagnardi V, Spector TD, Bell JT, Gieger C, Valdes AM, Menni C.
Diabetes. 2023 Dec 01. 72(12):1870-1880. PMID: 37699401
Plasma protein N-glycome composition associates with postprandial lipaemic response.
Louca P, Štambuk T, Frkatovic-Hodžic A, Nogal A, Mangino M, Berry SE, Deriš H, Hadjigeorgiou G, Wolf J, Vinicki M, Franks PW, Valdes AM, Spector TD, Lauc G, Menni C.
BMC Med. 2023 07 03. 21(1):231. PMID: 37400796
The secondary bile acid isoursodeoxycholate correlates with post-prandial lipemia, inflammation, and appetite and changes post-bariatric surgery.
Louca P, Meijnikman AS, Nogal A, Asnicar F, Attaye I, Vijay A, Kouraki A, Visconti A, Wong K, Berry SE, Leeming ER, Mompeo O, Tettamanzi F, Baleanu AF, Falchi M, Hadjigeorgiou G, Wolf J, Acherman YIZ, Van de Laar AW, Gerdes VEA, Michelotti GA, Franks PW, Segata N, Mangino M, Spector TD, Bulsiewicz WJ, Nieuwdorp M, Valdes AM, Menni C.
Cell Rep Med. 2023 04 18. 4(4):100993. PMID: 37023745
Genetic and gut microbiome determinants of SCFA circulating and fecal levels, postprandial responses and links to chronic and acute inflammation.
Nogal A, Asnicar F, Vijay A, Kouraki A, Visconti A, Louca P, Wong K, Baleanu AF, Giordano F, Wolf J, Hadjigeorgiou G, Davies R, Michelotti GA, Franks PW, Berry SE, Falchi M, Ikram A, Ollivere BJ, Zheng A, Nightingale J, Mangino M, Segata N, Bulsiewicz WJ, Spector TD, Valdes AM, Menni C.
Gut Microbes. 2023 Jan-Dec. 15(1):2240050. PMID: 37526398
Cross-Sectional Blood Metabolite Markers of Hypertension: A Multicohort Analysis of 44,306 Individuals from the COnsortium of METabolomics Studies.
Louca P, Nogal A, Moskal A, Goulding NJ, Shipley MJ, Alkis T, Lindbohm JV, Hu J, Kifer D, Wang N, Chawes B, Rexrode KM, Ben-Shlomo Y, Kivimaki M, Murphy RA, Yu B, Gunter MJ, Suhre K, Lawlor DA, Mangino M, Menni C.
Metabolites. 2022 Jun 28. 12(7). PMID: 35888725
Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study.
Menni C, Valdes AM, Polidori L, Antonelli M, Penamakuri S, Nogal A, Louca P, May A, Figueiredo JC, Hu C, Molteni E, Canas L, Österdahl MF, Modat M, Sudre CH, Fox B, Hammers A, Wolf J, Capdevila J, Chan AT, David SP, Steves CJ, Ourselin S, Spector TD.
Lancet. 2022 04 23. 399(10335):1618-1624. PMID: 35397851
Incremental Value of a Panel of Serum Metabolites for Predicting Risk of Atherosclerotic Cardiovascular Disease.
Nogal A, Louca P, Tran TQB, Bowyer RC, Christofidou P, Steves CJ, Berry SE, Wong K, Wolf J, Franks PW, Mangino M, Spector TD, Valdes AM, Padmanabhan S, Menni C.
J Am Heart Assoc. 2022 02 15. 11(4):e024590. PMID: 35156414
News
Symposium explores microbiome’s roles in cancer
At the 6th annual symposium of the Harvard Chan Microbiome in Public Health Center, experts from around the world discussed the many ways that the microbiome contributes to the development and treatment of cancer.
